Examples of 'hbeag' in a sentence
Meaning of "hbeag"
hbeag (noun) - in medical terminology, an abbreviation for hepatitis B e antigen, a protein associated with active hepatitis B virus replication
How to use "hbeag" in a sentence
Basic
Advanced
hbeag
Loss of HBeAg is correlated with an improved prognosis.
Detection of mutants in the HBeAg region.
Cumulative HBeAg seroconversion rates.
There are no data from which to make a recommendation for HBeAg positive patients.
The presence of HBeAg indicates an extremely high viral inoculum and active virus replication.
Experience in nucleoside naive patients HBeAg positive and negative.
The presence of HBeAg indicates that the virus is actively multiplying and is highly contagious.
Calcagno et al compared entecavir and lamivudine in HBeAg positive and negative patients.
HBeAg is a serological marker of increased viral replication.
Two patients became negative for HBeAg while one remained HBeAg positive.
HBeAg is detected only in HBsAg positive serum.
Experience in patients with HBeAg positive CHB and compensated liver disease.
HBeAg appears in the blood shortly after HBsAg.
The infecting HBV variants show mutations in the precore region that hamper HBeAg production.
HBeAg is a marker of high levels of replication of the virus.
See also
ALT normalisation HBeAg seroconversion HBeAg loss.
HBeAg is associated with viral replication and high infectiousness.
Experience in patients with HBeAg negative CHB.
HBeAg in serum is associated with viral replication and high infectivity.
The C gene codes for HBeAg and HBcAg.
HBeAg expression can be regulated at the transcriptional and translational level.
The increase in prevalence of HBeAg non-reagents is a worldwide tendency.
HBeAg seroconversion and loss assessed only in patients with detectable HBeAg at baseline.
Efficacy parameters in compensated HBeAg positive and HBeAg negative patients at week 48.
HBeAg positivity of the source case Perrillo et al.
Samples were previously tested for the presence of HBeAg or for anti-HBe.
HBeAg positive and HBeAg negative chronic hepatitis B with compensated liver disease.
The pCMV-rHBe construct encodes a secreted form of HBeAg carrying foreign epitopes.
HBeAG and HBV DNA are determined to assess whether patient needs antiviral therapy.
Prior to treatment the animal was positive for both HBeAg and anti-HBe.
In HBeAg positive patients without cirrhosis, treatment should be administered for at least.
Entecavir was deemed to be more cost-effective than lamivudine in HBeAg positive and negative patients.
In HBeAg negative patients without cirrhosis, treatment should be administered at least until.
In one embodiment, the HBV-associated disorder is chronic hepatitis and the subject is HBeAg positive.
Following HBeAg seroconversion, serologic response and clinical remission are generally durable after stopping lamivudine.
In another case, the HBV antigen is HBeAg.
HBeAg is produced by proteolytic processing of the pre-core protein.
In another embodiment, the HBV antigen is HBeAg.
HBeAg - correlates with the viral replication and infectivity.
In one embodiment, a subject having CHB is HBeAg positive.
Patients were all HBeAg positive and had median CD4 cell count of.
In one case, a subject having CHB is HBeAg positive.
Cumulative HBeAg seroconversion rates in patients with undetectable HBV DNA at week 24.
In another embodiment, a subject having CHB is HBeAg negative.
Serology HBeAg loss / seroconversiond.
This risk is as high as 90 % if the mother is also positive for HBeAg.
In this phase, HBeAg is detectable.
The HBeAg seroconversion ranged in time from four to 11 months.
In liver biopsy, immunofluorescence HBcAg and HBeAg are positive from 2 to 4 months.
For HBeAg positive patients, seroconversion HBeAg / Anti-HBe was considered to be the outcome of efficacy.
